SCWorx Corp.
A filing-based review of operating performance, liquidity, equity financing, material corporate developments and documented capital-market events.
1. Business and financial performance
In an October 2026 Form 8-K, SCWorx reported that a Nasdaq Hearings Panel reconsidered its earlier delisting decision and determined that it had regained continued-listing compliance, subject to conditions including a one-year monitor. Its earlier 1-for-12 reverse split and September private placement were material to that process.
2. Liquidity and going concern
A separate, filing-supported assessment of liquidity and going-concern status is not established in this edition.
3. Equity financing and dilution
The issuer reported that 449,860 shares were issued through a private placement, warrant exercises and placement-agent shares in the September compliance process. The impact on holders requires a share-count reconciliation.
The company received $938,000 in gross placement proceeds before expenses, subject to investor rescission rights linked to Nasdaq trading. The transaction increased public float, but the placement agent also received 49,860 fee shares. Gross proceeds should not be confused with net cash available to operations.
Primary documentation: SEC 8-K — securities purchase and placement agency agreements ↗ SEC 8-K — listing and investor rescission rights ↗
4. Exchange listing and trading events
No exchange-listing or trading event has been established from the source material included in this edition.
5. Strategic developments and corporate actions
An October 2026 Form 8-K reports Nasdaq panel reconsideration, a one-year monitoring condition and a prior 1-for-12 reverse split. Reinstatement is subject to conditions.
Primary document: Review underlying regulatory source ↗
6. Evidence ledger
7. Research conclusion
The evidence included in this edition is insufficient for a directional investment conclusion.
Documented filing analysis: Private placement and conditional listing reinstatement
SCWorx entered a September 16, 2026 private placement for 350,000 common shares and warrants covering 350,000 additional shares, raising $938,000 gross at a combined $2.68 per share-and-warrant unit. Warrants carry a $2.56 exercise price. The company also issued 49,860 shares to its placement agent. The individual accredited investors were not named in the narrative filing.
On October 2, 2026, a Nasdaq Hearings Panel reconsidered a delisting decision and determined that the company had regained continued-listing compliance subject to a one-year panel monitor and other conditions. The private-placement investors had conditional termination rights, creating a link between financing permanence and trading reinstatement.
Primary document: Open underlying filing or issuer document ↗
Independent research and non-compensation disclosure
Unsolicited, non-sponsored proprietary research. AnalystPitch.com independently selected SCWorx Corp. as the subject of this report and initiated its preparation and publication on its own initiative. SCWorx Corp. did not request, commission, sponsor, direct, or authorize this publication and had no involvement in the research process, editorial decisions, or approval of the report.
Compensation received or promised for this publication: US$0.00. AnalystPitch.com states that it has received no cash, securities, warrants, options, expense reimbursement, or other direct or indirect consideration from SCWorx Corp. or anyone acting on its behalf in exchange for preparing, publishing, or distributing this report, and that no such consideration has been promised. This report is not paid securities promotion or issuer-sponsored research.
Section 17(b) transparency. Section 17(b) of the Securities Act of 1933 addresses certain securities publicity published for consideration received directly or indirectly from an issuer, underwriter, or dealer. The compensation statement above describes the circumstances of this report; it is not a claim that the SEC has reviewed, approved, or certified the report or this disclosure.
Other potential conflicts. The absence of payment for this publication does not by itself establish the absence of other financial interests or relationships. Any material securities holdings, financing arrangements, advisory engagements, or other relevant conflicts involving the publisher or its responsible contributors should be separately disclosed where applicable.
This publication is informational research, not personalized investment advice, an offer to sell securities, or a solicitation to purchase securities.
9. Primary documents
Primary referenced regulatory filing or source ↗
SEC EDGAR — search subsequent company filings ↗
Information cutoff: 13 October 2026. Not all financial line items have been independently recalculated. This report does not purport to reproduce a full audited financial model. Information can become outdated after the cutoff.